Pricing

Log inSign up

SalioGen Therapeutics

1 follower

‌

SalioGen Therapeutics is advancing the Exact DNA Integration Technology (EDIT) platform, the only genome engineering technology that is mammal-derived, for use in potentially curative non-viral gene therapy.

Industries

Biotechnology, Education

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Jason F. Cole
CEO & Chairman

Jason F. Cole

Collapse
Will Mcgown
Executive Director, Finance & FP&A
Jill Murray
VP, Human Resources
Joseph J. Higgins
President & Chief Scientific Officer
Jeff Kopacz
SVP of Intellectual Property & Contracts
Joe Senn
SVP & Head of R&D
Jill Murray, PHR
Vice President Human Resources
Oleg Iartchouk
Vice President, Biomarkers And Genomics
William McGowan
Executive Director, Finance And Fp&a
Subhro Guhathakurta
Executive Director, Platform Development & Genetic Engineering
SJ
Sujit Jain
Sr Director, CMC Operations
LauraLee Hughes
Director, Corporate Development & Strategy
QB
Quinner Baltazar
Associate Director
Pat Sacco
SVP of Manufacturing, Quality & Operations
Sandeep Nema
SVP, Technical Operations

Teams

BD
+11

Scientific Advisory and Development

14 members

+4

Scientific Research

7 members

+3

Leadership Team

6 members

Similar companies

Jeeves

4 followers

Jnana Therapeutics

1 follower

Sonoma Biotherapeutics

1 follower

4D Molecular Therapeutics

3 followers

Pivot Bio

2 followers

Quantum-Si

2 followers

Immunome

2 followers

Classera

2 followers

Amgen

208 followers

IIT Gandhinagar

3 followers

eBay

361 followers

Explore companies